Alcoholic liver and pancreatic diseases (ALPD) and cirrhosis constitute leading life-style diseases around the globe. The Southern California Research Center for ALPD and Cirrhosis unifies 57 investigators from major academic institutions in Southern California to pursue a common mission of being a leader in research, training, and outreach for the diseases. The center, since its inception in 1999, has devoted its efforts for development and use of clinically relevant animal models to gain novel insights into the molecular mechanisms underlying the predisposition to advanced ALPD. These efforts culminated to recent groundbreaking discoveries which have significantly advanced our understanding of synergistic ALPD caused by alcohol and a second hit. The center's interactive environment and infrastructure have facilitated in the past 5 years, a 152% increase in research base to $8.5M/year;4 new U01/P01 programs;198 publications;generation of 14 NIH-funded early-stage investigators;transition of 8 postdocs to faculty positions;training 166 graduate and 20 undergraduate students;and organizing 3 community seminars and 4 international symposia. As a unique national resource, the center has provided to scientific communities across the nation: 229 rodents as ALPD models and 241 model samples for 17 outside investigators;329 liver cell isolation preparations for 14 investigators;and support for grant acquisition and application by 12 outside investigators since the last renewal. The center will continue to strive as a unique scientific center of excellence in ALPD and cirrhosis by promoting: 1) environment conducive for leading-edge research on the center's theme: elucidation of the priming and sensitizing mechanisms for ALPD;2) provision of unique models, innovative genetic approaches and expertise to outside investigators including those at other NIAAA Alcohol Research Centers;3) comprehensive education and training to foster future generations of scientists in ALPD and cirrhosis;and 4) outreach efforts to disseminate the center's new findings to lay public, health care workers and scientists in our home and global communities.

Public Health Relevance

ALPD and cirrhosis are the major medical consequences of alcohol abuse and prevalent life-style diseases around the world. Our center's consorted efforts for research, training, and dissemination, and the outcome from these activities help advance the understanding of the diseases and develop novel preventive and therapeutic approaches.

National Institute of Health (NIH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAA1-GG (50))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Southern California
Los Angeles
United States
Zip Code
Lazaro, Raul; Wu, Raymond; Lee, Sunyoung et al. (2015) Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice. Hepatology 61:129-40
Peng, Yue; French, Barbara A; Tillman, Brittany et al. (2014) The inflammasome in alcoholic hepatitis: Its relationship with Mallory-Denk body formation. Exp Mol Pathol 97:305-13
Ooi, Ee Lyn; Chan, Stephanie T; Cho, Noell E et al. (2014) Novel antiviral host factor, TNK1, regulates IFN signaling through serine phosphorylation of STAT1. Proc Natl Acad Sci U S A 111:1909-14
Win, S; Than, T A; Fernandez-Checa, J C et al. (2014) JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death. Cell Death Dis 5:e989
Kong, Ming; Zhu, Longdong; Bai, Li et al. (2014) Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. Am J Physiol Gastrointest Liver Physiol 307:G883-93
Ji, Cheng (2014) New Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver Diseases. Int J Hepatol 2014:513787
Lua, Ingrid; James, David; Wang, Jiaohong et al. (2014) Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury. Hepatology 60:311-22
Schnabl, Bernd; Brenner, David A (2014) Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146:1513-24
McArdle, Patrick F; Kittner, Steven J; Ay, Hakan et al. (2014) Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study. Neurology 83:1653-60
Shen, Hong; French, Barbara A; Liu, Hui et al. (2014) Increased activity of the complement system in the liver of patients with alcoholic hepatitis. Exp Mol Pathol 97:338-44

Showing the most recent 10 out of 273 publications